drugset / Trial / NCT00371033
Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Phase 3
Completed
324 enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether pregabalin is an effective treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-01
- Completion
- 2008-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 200 mg | Oral |